PPC
Propanc Biopharma, Inc. Common Stock
PPCB • NASDAQ
Propanc Biopharma, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO James Nathanielsz, with a market cap of $2.1M.
Market Cap$2.1M
CEOJames Nathanielsz
CountryUnited States of America
Next EarningsMay 16, 2026 · in a monthQ3 2026
Financials
PPC
Propanc Biopharma, Inc. Common Stock FAQ
Common questions about Propanc Biopharma, Inc. Common Stock
Propanc Biopharma, Inc. Common Stock is scheduled to report earnings for Q3 2026 on May 16, 2026.